Cosette Drug Patent Portfolio
Cosette owns 14 orange book drugs protected by 81 US patents with Evoxac having the least patent protection, holding only 1 patent. And Welchol with maximum patent protection, holding 26 patents. Given below is the list of Cosette's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590209 | Use of bremelanotide in patients with controlled hypertension | 29 Apr, 2041 | Active |
| US11541002 | Oral film compositions and dosage forms having precise active dissolution profiles | 31 Jan, 2040 | Active |
| US12290597 | Oral Film Compositions And Dosage Forms Having Precise Active Dissolution Profiles | 05 Sep, 2039 | Active |
| US12403090 | Oral Film Compositions And Dosage Forms Having Precise Active Dissolution Profiles | 05 Sep, 2039 | Active |
| US10286034 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US9352013 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US9700592 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US8814834 | Injector safety device | 27 May, 2031 | Active |
| US11497753 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US12357642 | Hazardous Agent Injection System | 19 Mar, 2030 | Active |
| US8480631 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US8579865 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US8945063 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US9421333 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US10709844 | Injector safety device | 10 Mar, 2029 | Active |
| US11684723 | Injector safety device | 10 Mar, 2029 | Active |
| US9867949 | Injector safety device | 10 Mar, 2029 | Active |
| US7662858 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US7884095 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US7939518 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US8110606 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US8623920 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US9561200 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US8021335 | Prefilled syringe jet injector | 04 Oct, 2026 | Active |
| US7759394 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Expired |
| US8097651 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Expired |
| US8927604 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Expired |
| US9827197 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Expired |
| US11446441 | Prefilled syringe injector | 24 Jan, 2026 | Expired |
| US8562564 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9533102 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9629959 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US6794489 | Compositions and methods for treatment of sexual dysfunction | 28 Jun, 2025 | Expired |
| US8603514 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions | 03 Apr, 2024 | Expired |
| US8765167 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions | 20 Feb, 2024 | Expired |
| US8404703 | Medicinal compositions containing aspirin | 02 Jul, 2023 | Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel | 02 Jul, 2023 | Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel | 02 Jan, 2023 | Expired |
| US7229613 | Method for lowering serum glucose | 17 Oct, 2022 | Expired |
| US6878703 | Pharmaceutical composition | 19 May, 2022 | Expired |
| US7229613 | Method for lowering serum glucose | 17 Apr, 2022 | Expired |
| US8404703 | Medicinal compositions containing aspirin | 02 Mar, 2022 | Expired |
| US6878703 | Pharmaceutical composition | 19 Nov, 2021 | Expired |
| US6693115 | Acid addition salts of hydropyridine derivatives | 03 Jul, 2021 | Expired |
| US6579968 | Compositions and methods for treatment of sexual dysfunction | 28 Jun, 2021 | Expired |
| US6514531 | Controlled-release dosage forms comprising zolpidem or a salt thereof | 01 Jun, 2020 | Expired |
| US6746429 | Needle assisted jet injector | 12 Apr, 2020 | Expired |
| US6514531 | Controlled-release dosage forms comprising zolpidem or a salt thereof | 01 Dec, 2019 | Expired |
| US7744582 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| US7776015 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| USRE44846 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| USRE44847 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| US6365180 | Oral liquid compositions | 15 Jul, 2019 | Expired |
| US6287594 | Oral liquid compositions | 15 Jan, 2019 | Expired |
| US6333044 | Therapeutic compositions for intranasal administration which include KETOROLAC® | 25 Dec, 2018 | Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | 14 Oct, 2017 | Expired |
| US6974595 | Pharmaceutical compositions based on Diclofenae | 15 May, 2017 | Expired |
| US7482377 | Pharmaceutical compositions and methods of treatment based on diclofenac | 15 May, 2017 | Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | 14 Apr, 2017 | Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use | 25 Oct, 2016 | Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use | 25 Apr, 2016 | Expired |
| US5693675 | Alkylated amine polymers | 02 Jun, 2015 | Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion | 10 Dec, 2014 | Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion | 10 Dec, 2014 | Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Dec, 2014 | Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Dec, 2014 | Expired |
| US5693675 | Alkylated amine polymers | 02 Dec, 2014 | Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers | 29 Oct, 2014 | Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion | 10 Jun, 2014 | Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion | 10 Jun, 2014 | Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Jun, 2014 | Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Jun, 2014 | Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers | 29 Apr, 2014 | Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US5340821 | Composition and method for treating Sjoegren syndrome disease | 07 Jul, 2013 | Expired |
| US7476689 | Therapeutic compositions for intranasal administration which include KETOROLAC | 11 Oct, 2012 | Expired |
Latest Legal Activities on Cosette's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cosette.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent | 12 Jan, 2026 | US8603514 (Litigated) |
| Email Notification | 22 Oct, 2025 | US8097651 |
| Change in Power of Attorney (May Include Associate POA) | 22 Oct, 2025 | US8097651 |
| Recordation of Patent Grant Mailed | 09 Sep, 2025 | US12403090 |
| Patent eGrant Notification | 02 Sep, 2025 | US12403090 |
| Patent Issue Date Used in PTA Calculation | 02 Sep, 2025 | US12403090 |
| Mail Patent eGrant Notification | 02 Sep, 2025 | US12403090 |
| Recordation of Patent eGrant | 02 Sep, 2025 | US12403090 |
| Issue Notification Mailed | 20 Aug, 2025 | US12403090 |
| Maintenance Fee Reminder Mailed | 28 Jul, 2025 | US8603514 (Litigated) |
| Dispatch to FDC | 25 Jul, 2025 | US12403090 |
| Application Is Considered Ready for Issue | 25 Jul, 2025 | US12403090 |
| Mail Response to 312 Amendment (PTO-271) | 23 Jul, 2025 | US12403090 |
| Response to Amendment under Rule 312 | 22 Jul, 2025 | US12403090 |
| Recordation of Patent Grant Mailed | 22 Jul, 2025 | US12357642 |
Cosette's Drug Patent Litigations
Cosette's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jun 13, 1997, against patent number US6333044. The petitioner , challenged the validity of this patent, with SANTUS et al as the respondent. Click below to track the latest information on how companies are challenging Cosette's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8603514 | June, 2017 |
Institution Denied
(20 Oct, 2017)
| MonoSol Rx, LLC et al. | Par Pharmaceutical, Inc. et al. |
| US8603514 | June, 2017 |
Institution Denied
(20 Oct, 2017)
| MonoSol Rx, LLC et al. | Dr. Reddy’s Laboratories, Inc. et al. |
| US8603514 | November, 2016 |
Terminated-Settled
(06 Oct, 2017)
| MonoSol Rx, LLC et al. | Mylan Technologies, Inc. et al. |
| US8603514 | May, 2016 |
Institution Denied
(05 Dec, 2016)
| MonoSol Rx, LLC et al. | Dr. Reddy's Laboratories, Inc. et al. |
| US8404703 | March, 2015 |
Final Written Decision
(12 Sep, 2016)
| DAIICHI SANKYO COMPANY, LIMITED et al. | Accord Healthcare Inc., USA et al. |
| US8404703 | October, 2015 |
Final Written Decision
(12 Sep, 2016)
| Daiichi Sankyo Co., Ltd. et al. | Lupin, Ltd. et al. |
| US8569325 | March, 2015 |
Final Written Decision
(12 Sep, 2016)
| DAIICHI SANKYO COMPANY, LIMITED et al. | Accord Healthcare Inc., USA et al. |
| US8569325 | October, 2015 |
Final Written Decision
(12 Sep, 2016)
| Daiichi Sankyo Co., Ltd. et al. | Lupin, Ltd. et al. |
| US8603514 | December, 2015 |
Institution Denied
(23 May, 2016)
| MONOSOL RX LLC et al. | Teva Pharmaceuticals USA Inc |
| US8765167 | October, 2014 |
Final Written Decision
(24 Mar, 2016)
| MonoSol Rx, LLC. et al. | BioDelivery Sciences International, Inc. |
| US8765167 | October, 2014 |
Terminated-Settled
(24 Mar, 2016)
| MonoSol Rx, LLC. et al. | BioDelivery Sciences International, Inc. |
| US8404703 | June, 2015 |
Institution Denied
(07 Jan, 2016)
| DAIICHI SANKYO COMPANY, LIMITED et al. | Panacea Biotec Ltd. |
| US8569325 | June, 2015 |
Institution Denied
(07 Jan, 2016)
| DAIICHI SANKYO COMPANY, LIMITED et al. | Panacea Biotec Ltd. |
| US8765167 | October, 2014 |
Institution Denied
(20 May, 2015)
| MonoSol Rx, LLC. et al. | BioDelivery Sciences International, Inc. |
| US6333044 | June, 1997 |
Decision
(28 Aug, 2000)
| SANTUS et al | |
Cosette Drug Patents' Oppositions Filed in EPO
Cosette drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 11, 2012, by Lts Lohmann Therapie-Systeme Ag. This opposition was filed on patent number EP02801042A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP19150366A | Sep, 2022 | Bandpay & Greuter | Granted and Under Opposition |
| EP06719329A | Oct, 2019 | Bandpay & Greuter | Patent maintained as amended |
| EP13851014A | Jun, 2019 | Teva Pharmaceutical Industries Ltd. | Granted and Under Opposition |
| EP09719763A | Jun, 2016 | Ypsomed AG | Revoked |
| EP11157819A | Jun, 2014 | Ahrens, Gabriele | Patent maintained as amended |
| EP02782151A | Jun, 2013 | Acino Pharma AG | Revoked |
| EP02782151A | Jun, 2013 | Germann, Sandra | Revoked |
| EP02801042A | Sep, 2012 | Ahrens, Gabriele | Patent maintained as amended |
| EP02801042A | Sep, 2012 | LTS LOHMANN Therapie-Systeme AG | Patent maintained as amended |
Cosette's Family Patents
Cosette Drug List
Given below is the complete list of Cosette's drugs and the patents protecting them.
1. Ambien Cr
Ambien Cr is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6514531
(Pediatric)
| Controlled-release dosage forms comprising zolpidem or a salt thereof |
01 Jun, 2020
(6 years ago)
| Expired |
| US6514531 | Controlled-release dosage forms comprising zolpidem or a salt thereof |
01 Dec, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ambien Cr's drug page
2. Azor
Azor is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(9 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azor's drug page
3. Benicar
Benicar is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6878703
(Pediatric)
| Pharmaceutical composition |
19 May, 2022
(4 years ago)
| Expired |
| US6878703 | Pharmaceutical composition |
19 Nov, 2021
(4 years ago)
| Expired |
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(9 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar's drug page
4. Benicar Hct
Benicar Hct is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6878703
(Pediatric)
| Pharmaceutical composition |
19 May, 2022
(4 years ago)
| Expired |
| US6878703 | Pharmaceutical composition |
19 Nov, 2021
(4 years ago)
| Expired |
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(9 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar Hct's drug page
5. Cambia
Cambia is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7759394 | Diclofenac formulations and methods of use |
16 Jun, 2026
(30 days ago)
| Expired |
| US8097651 | Diclofenac formulations and methods of use |
16 Jun, 2026
(30 days ago)
| Expired |
| US8927604 | Diclofenac formulations and methods of use |
16 Jun, 2026
(30 days ago)
| Expired |
| US9827197 | Diclofenac formulations and methods of use |
16 Jun, 2026
(30 days ago)
| Expired |
| US6974595 | Pharmaceutical compositions based on Diclofenae |
15 May, 2017
(9 years ago)
| Expired |
| US7482377 | Pharmaceutical compositions and methods of treatment based on diclofenac |
15 May, 2017
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cambia's drug page
Explore Our Curated Drug Screens
6. Effient
Effient is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8404703
(Pediatric)
| Medicinal compositions containing aspirin |
02 Jul, 2023
(3 years ago)
| Expired |
| US8569325
(Pediatric)
| Method of treatment with coadministration of aspirin and prasugrel |
02 Jul, 2023
(3 years ago)
| Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel |
02 Jan, 2023
(3 years ago)
| Expired |
| US8404703 | Medicinal compositions containing aspirin |
02 Mar, 2022
(4 years ago)
| Expired |
| US6693115 | Acid addition salts of hydropyridine derivatives |
03 Jul, 2021
(5 years ago)
| Expired |
| US5288726
(Pediatric)
| Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
14 Oct, 2017
(8 years ago)
| Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
14 Apr, 2017
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Effient's drug page
7. Evoxac
Evoxac is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5340821 | Composition and method for treating Sjoegren syndrome disease |
07 Jul, 2013
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoxac's drug page
8. Otrexup
Otrexup is protected by 20 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8814834 | Injector safety device |
27 May, 2031
(4 years from now)
| Active |
| US11497753 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US12357642 | Hazardous Agent Injection System |
19 Mar, 2030
(3 years from now)
| Active |
| US8480631 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US8579865 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US8945063 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US9421333 | Hazardous agent injection system |
19 Mar, 2030
(3 years from now)
| Active |
| US10709844 | Injector safety device |
10 Mar, 2029
(2 years from now)
| Active |
| US11684723 | Injector safety device |
10 Mar, 2029
(2 years from now)
| Active |
| US9867949 | Injector safety device |
10 Mar, 2029
(2 years from now)
| Active |
| US8021335 | Prefilled syringe jet injector |
04 Oct, 2026
(2 months from now)
| Active |
| US11446441 | Prefilled syringe injector |
24 Jan, 2026
(5 months ago)
| Expired |
| US8562564 | Prefilled syringe jet injector |
24 Jan, 2026
(5 months ago)
| Expired |
| US9533102 | Prefilled syringe jet injector |
24 Jan, 2026
(5 months ago)
| Expired |
| US9629959 | Prefilled syringe jet injector |
24 Jan, 2026
(5 months ago)
| Expired |
| US6746429 | Needle assisted jet injector |
12 Apr, 2020
(6 years ago)
| Expired |
| US7744582 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
| US7776015 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
| USRE44846 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
| USRE44847 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Otrexup's drug page
9. Sprix
Sprix is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6333044 | Therapeutic compositions for intranasal administration which include KETOROLAC® |
25 Dec, 2018
(7 years ago)
| Expired |
| US7476689 | Therapeutic compositions for intranasal administration which include KETOROLAC |
11 Oct, 2012
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sprix's drug page
10. Sympazan
Sympazan is protected by 5 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11541002 | Oral film compositions and dosage forms having precise active dissolution profiles |
31 Jan, 2040
(13 years from now)
| Active |
| US12290597 | Oral Film Compositions And Dosage Forms Having Precise Active Dissolution Profiles |
05 Sep, 2039
(13 years from now)
| Active |
| US12403090 | Oral Film Compositions And Dosage Forms Having Precise Active Dissolution Profiles |
05 Sep, 2039
(13 years from now)
| Active |
| US8603514 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
03 Apr, 2024
(2 years ago)
| Expired |
| US8765167 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
20 Feb, 2024
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sympazan's drug page
11. Tribenzor
Tribenzor is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(9 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tribenzor's drug page
12. Vyleesi (autoinjector)
Vyleesi (autoinjector) is protected by 6 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590209 | Use of bremelanotide in patients with controlled hypertension |
29 Apr, 2041
(14 years from now)
| Active |
| US10286034 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(7 years from now)
| Active |
| US9352013 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(7 years from now)
| Active |
| US9700592 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(7 years from now)
| Active |
| US6794489 | Compositions and methods for treatment of sexual dysfunction |
28 Jun, 2025
(1 year, 18 days ago)
| Expired |
| US6579968 | Compositions and methods for treatment of sexual dysfunction |
28 Jun, 2021
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vyleesi (autoinjector)'s drug page
13. Welchol
Welchol is protected by 26 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7229613
(Pediatric)
| Method for lowering serum glucose |
17 Oct, 2022
(3 years ago)
| Expired |
| US7229613 | Method for lowering serum glucose |
17 Apr, 2022
(4 years ago)
| Expired |
| US5693675
(Pediatric)
| Alkylated amine polymers |
02 Jun, 2015
(11 years ago)
| Expired |
| US5607669
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
10 Dec, 2014
(11 years ago)
| Expired |
| US5919832
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
10 Dec, 2014
(11 years ago)
| Expired |
| US6066678
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
10 Dec, 2014
(11 years ago)
| Expired |
| US6433026
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
10 Dec, 2014
(11 years ago)
| Expired |
| US5693675 | Alkylated amine polymers |
02 Dec, 2014
(11 years ago)
| Expired |
| US5679717
(Pediatric)
| Method for removing bile salts from a patient with alkylated amine polymers |
29 Oct, 2014
(11 years ago)
| Expired |
| US5917007
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(11 years ago)
| Expired |
| US5919832
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
29 Oct, 2014
(11 years ago)
| Expired |
| US6066678
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(11 years ago)
| Expired |
| US6433026
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(11 years ago)
| Expired |
| US6784254
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(11 years ago)
| Expired |
| US7101960
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(11 years ago)
| Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion |
10 Jun, 2014
(12 years ago)
| Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
10 Jun, 2014
(12 years ago)
| Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
10 Jun, 2014
(12 years ago)
| Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
10 Jun, 2014
(12 years ago)
| Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers |
29 Apr, 2014
(12 years ago)
| Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(12 years ago)
| Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
29 Apr, 2014
(12 years ago)
| Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(12 years ago)
| Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(12 years ago)
| Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(12 years ago)
| Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Welchol's drug page
14. Zipsor
Zipsor is protected by 8 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7662858 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US7884095 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US7939518 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US8110606 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US8623920 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US9561200 | Method of treating post-surgical acute pain |
24 Feb, 2029
(2 years from now)
| Active |
| US6365180 | Oral liquid compositions |
15 Jul, 2019
(7 years ago)
| Expired |
| US6287594 | Oral liquid compositions |
15 Jan, 2019
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zipsor's drug page